Genotype-guided dual antiplatelet use for TIA and minor stroke by imaging status: a subgroup analysis of the CHANCE-2 trial.
Jing JingXuewei XieS Claiborne JohnstonPhilip M BathZi-Xiao LiXing-Quan ZhaoLiping LiuYilong WangQin XuAnxin WangYong JiangHao LiXia MengYongjun Wangnull nullPublished in: Annals of neurology (2022)
Our study demonstrate that imaging evaluation should be emphasized before targeting the best candidates for genotype-guided dual antiplatelet therapy in future clinical research and practice. This article is protected by copyright. All rights reserved.